COMP <GO>
EQIX vs MS // PIOTROSKI F-SCORE QUALITY
Equinix Inc. Common Stock REIT (NASDAQ) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: EQIX 7
— MS 8
▲ PIOTROSKI F-SCORE QUALITY LEADER: EQIX
LAST: $1,013.70 (-2.22%) • MKT CAP: $102.62B
piotroski-score
9/9
LAST: $184.30 (-3.00%) • MKT CAP: $298.41B
piotroski-score
5/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EQIX VS. MS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EQIX | MS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 51.10% | 41.00% | +10.10 | EQIX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.30% | 3.00% | +3.30 | EQIX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 50.8x | 31.0x | +19.80 | MS | /valuation <GO> |
| Free Cash Flow Yield | 3.41% | -7.25% | +10.66 | EQIX | /fcf-yield <GO> |
| Operating Margin | 20.00% | 24.60% | -4.60 | MS | /operating-margins <GO> |
| Net Profit Margin | 14.60% | 20.20% | -5.60 | MS | /net-margins <GO> |
| Revenue Growth (YoY) | 5.40% | 5.50% | -0.10 | MS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.81% | 2.21% | -0.40 | MS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.00 | 0.46 | +2.54 | EQIX | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 9/9 | 5/9 | +4.00 | EQIX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.00% | -0.40 | EQIX | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.8 | 43.3 | +8.46 | EQIX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 1.04 | -0.13 | MS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 70.7x | 16.5x | +54.20 | MS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $102.62B | $298.41B | -$195.79B | MS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EQIX REV | MS REV | EQIX GROSS % | MS GROSS % | EQIX FCF | MS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.22B | $0 | 51.1% | — | $3.50B | -$17.89B |
| FY 2024 | $8.75B | $0 | 48.9% | — | $2.86B | $1.36B |
| FY 2023 | $8.19B | $0 | 44.0% | — | $2.85B | -$33.54B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EQIX // BETA 0.91
MS // BETA 1.04